Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Business Herald.
Press releases published on August 12, 2025
Urgently Announces Second Quarter 2025 Financial Results
ASHBURN, Va., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the second quarter ended June …
Prairie Operating Co. Announces Second Quarter 2025 Results
Total Revenue of $68.1 million, an increase of approximately 400% quarter-over-quarter Net Income of $35.7 million, an increase of over 500% quarter-over-quarter Over 540% increase in quarterly production to a total of 21,052 Boe/d per day (50% oil) Record …
Rekor Systems Reports Second Quarter 2025 Financial Results
Improved Adjusted EBITDA: Substantially narrowed Adjusted EBITDA loss by $2 million for the six-month period. Operating Expense Reduction: Reduced operating expenses by 17% quarter over quarter and year over year, reflecting strong cost discipline. …
Rigetti Computing Reports Second Quarter 2025 Financial Results; Announces General Availability of its 36-Qubit Multi-Chip Quantum Computer
BERKELEY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the second quarter ended June 30, 2025. …
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
CLEARFIELD, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a quarterly cash dividend of $0.18 per share of common stock payable on September 12, 2025 to common stock shareholders of record …
Zevra Reports Second Quarter 2025 Financial Results and Corporate Update
Q2 2025 net revenue of $25.9 million, driven by product net revenue of $21.8 million Completed sale of PRV for $150.0 million, bolstering the balance sheet as the Company executes on its commercial launches and development programs Submitted a Marketing …
ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferences and Events
ALBUQUERQUE, N.M., Aug. 12, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced its attendance at the following …
Diginex Announces MOU for US$305m Acquisition of Findings, a leading cybersecurity and compliance automation company
LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced the signing of a non-binding Memorandum of Understanding (MOU) to acquire 100% of …
Arbor Realty Trust Closes a $1.05 Billion Collateralized Loan Obligation Securitization
UNIONDALE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the closing of a $1.05 billion commercial real estate mortgage loan securitization (the “Securitization”). An aggregate of approximately $933 million …
LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth
LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the Company), a provider of personal safety, personal emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, …
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results
Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash, cash equivalents, and short-term investments now sufficient to fund operations into the first half of 2028 Expanded ongoing collaboration with Almirall, with …
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Received FDA feedback on Pre-IND Briefing Document reinforcing Company’s intention to advance investigational new drug (IND) submission for CUE-401 to address unmet need in the treatment of autoimmune disease. Announced strategic research collaboration and …
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Multiple near-term potential milestones, including anticipated completion of primary structure analysis and select functional analyses in 3Q’25 – – Type 2a meeting with the FDA anticipated in 4Q’25– – Cash runway expected to support operations through …
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 2025 – Phase 2 ASPEN-Breast evorpacept trial design …
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of LYL314 in patients with large B-cell …
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial design elements. Company expects to begin enrolling …
H&R Block Reports Fiscal 2025 Results and Provides Fiscal 2026 Outlook
- Delivered Revenue Growth of 4% and Earnings per Share Growth of 7% - - Returned $600 Million to Shareholders via Dividends and Share Repurchases - - Increases Quarterly Dividend by 12% - KANSAS CITY, Mo., Aug. 12, 2025 (GLOBE NEWSWIRE) -- H…
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
-- PIKture-01, a phase 1 clinical trial assessing OKI-219 in patients with advanced solid tumors, including breast cancer, is on track for single agent and fulvestrant combination data in Q4 2025 -- Initiated a new expansion arm of PIKture-01 to evaluate …
Varonis to Present at Upcoming Investor Conference
MIAMI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced its participation at the following upcoming conference: Citi's 2025 Global TMT Conference, September 2 – 5, in New York. The presentation …